TAMSULOSIN Drug Patent Profile

Which patents cover Tamsulosin, and when can generic versions of Tamsulosin launch?

Tamsulosin is a drug marketed by Alkem Labs Ltd, Ascent Pharms Inc, Aurobindo Pharma Ltd, Chartwell Rx, Impax Labs, Macleods Pharms Ltd, Ph Health, Pharmobedient, Rising, Sandoz, Sciegen Pharms, Sun Pharm Inds Ltd, Synthon Bv, Teva Pharms, and Zydus Pharms Usa Inc. and is included in fifteen NDAs.

The generic ingredient in TAMSULOSIN is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tamsulosin

A generic version of TAMSULOSIN was approved as tamsulosin hydrochloride by IMPAX LABS on March 2^nd, 2010.

Summary for TAMSULOSIN

US Patents:	0
Applicants:	15
NDAs:	15
Drug Prices:	Drug price information for TAMSULOSIN
Drug Sales Revenues:	Drug sales revenues for TAMSULOSIN
DailyMed Link:	TAMSULOSIN at DailyMed

See drug prices for TAMSULOSIN

See drug sales revenues for TAMSULOSIN

US Patents and Regulatory Information for TAMSULOSIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alkem Labs Ltd	TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	207405-001	Aug 11, 2017	AB	RX	No	No
Ph Health	TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	202010-001	Jan 4, 2013		DISCN	No	No
Chartwell Rx	TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	211885-001	Oct 17, 2019	AB	RX	No	No